Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue Sarcoma
Status:
Recruiting
Trial end date:
2024-12-30
Target enrollment:
Participant gender:
Summary
To evaluate the effectiveness and safety of radioactive particles in combination with the
PARP inhibitor fluzoparib in the treatment of advanced inoperable soft tissue sarcoma.